Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seymour Katz

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Hospital Practice (1995)|September 30, 2010
MMX mesalamine is safe and efficacious in achieving clinical and endoscopic remission of active ulcerative colitisSeymour Katz
The American Journal of Gastroenterology|November 11, 2005
A candidate's approach to a successful partnershipSeymour Katz
Journal of Clinical Gastroenterology|March 22, 2002
Update in medical therapy of ulcerative colitis: a practical approachSeymour Katz
Reviews in Gastroenterological Disorders|May 16, 2006
Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatmentSeymour Katz
Gastroenterology & Hepatology|August 21, 2013
Prevention, detection, and treatment of osteopenia and osteoporosisSeymour Katz
Journal of Clinical Gastroenterology|September 21, 2007
"Mind the Gap": an unmet need for new therapy in IBDSeymour Katz
Mayo Clinic Proceedings|August 6, 2013
My treatment approach to the management of ulcerative colitisSeymour Katz
Clinics in Geriatric Medicine|November 26, 2013
The aging patient populationSeymour Katz
Journal of Clinical Gastroenterology|July 8, 2005
Update in medical therapy of ulcerative colitis: newer concepts and therapiesSeymour Katz
Gastroenterology & Hepatology|March 24, 2017
Leukocytapheresis: An "Out-of-Body" Experience in Inflammatory Bowel DiseaseSeymour Katz
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Hospital Practice (1995)|September 30, 2010
MMX mesalamine is safe and efficacious in achieving clinical and endoscopic remission of active ulcerative colitisSeymour Katz
The American Journal of Gastroenterology|November 11, 2005
A candidate's approach to a successful partnershipSeymour Katz
Journal of Clinical Gastroenterology|March 22, 2002
Update in medical therapy of ulcerative colitis: a practical approachSeymour Katz
Reviews in Gastroenterological Disorders|May 16, 2006
Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatmentSeymour Katz
Gastroenterology & Hepatology|August 21, 2013
Prevention, detection, and treatment of osteopenia and osteoporosisSeymour Katz
Journal of Clinical Gastroenterology|September 21, 2007
"Mind the Gap": an unmet need for new therapy in IBDSeymour Katz
Mayo Clinic Proceedings|August 6, 2013
My treatment approach to the management of ulcerative colitisSeymour Katz
Clinics in Geriatric Medicine|November 26, 2013
The aging patient populationSeymour Katz
Journal of Clinical Gastroenterology|July 8, 2005
Update in medical therapy of ulcerative colitis: newer concepts and therapiesSeymour Katz
Gastroenterology & Hepatology|March 24, 2017
Leukocytapheresis: An "Out-of-Body" Experience in Inflammatory Bowel DiseaseSeymour Katz
Pageof 10